Joseph Brenden, Kerr Thomas, Puskas Cathy M, Montaner Julio, Wood Evan, Milloy M-J
a British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital , Vancouver , BC , Canada.
b Division of AIDS, Department of Medicine , University of British Columbia , Vancouver , BC , Canada.
AIDS Care. 2015;27(9):1128-36. doi: 10.1080/09540121.2015.1032205. Epub 2015 Apr 27.
HIV-positive people who use illicit drugs typically achieve lower levels of adherence to antiretroviral therapy and experience higher rates of sub-optimal HIV/AIDS treatment outcomes. Given the dearth of longitudinal research into ART adherence dynamics, we sought to identify factors associated with transitioning into and out of optimal adherence to ART in a longitudinal study of HIV-infected people who use illicit drugs (PWUD) in a setting of universal no-cost HIV/AIDS treatment. Using data from a prospective cohort of community-recruited HIV-positive illicit drug users confidentially linked to comprehensive HIV/AIDS treatment records, we estimated longitudinal factors associated with losing or gaining ≥95% adherence in the previous six months using two generalized linear mixed-effects models. Among 703 HIV-infected ART-exposed PWUD, becoming non-adherent was associated with periods of homelessness (adjusted odds ratio [AOR] = 2.52, 95% confidence interval [95% CI]: 1.56-4.07), active injection drug use (AOR = 1.25, 95% CI: 1.01-1.56) and incarceration (AOR = 1.54, 95% CI: 1.10-2.17). Periods of sex work (AOR = 0.51, 95% CI: 0.34-0.75) and injection drug use (AOR = 0.62, 95% CI: 0.50-0.77) were barriers to becoming optimally adherent. Methadone maintenance therapy was associated with becoming optimally adherent (AOR = 1.87, 95% CI: 1.50-2.33) and was protective against becoming non-adherent (AOR = 0.52, 95% CI: 0.41-0.65). In conclusion, we identified several behavioural, social and structural factors that shape adherence patterns among PWUD. Our findings highlight the need to consider these contextual factors in interventions that support the effective delivery of ART to this population.
使用非法药物的艾滋病毒呈阳性者通常对抗逆转录病毒疗法的依从性较低,并且次优的艾滋病毒/艾滋病治疗结果发生率较高。鉴于对抗逆转录病毒疗法依从性动态的纵向研究匮乏,我们试图在一项针对在普遍免费提供艾滋病毒/艾滋病治疗背景下使用非法药物的艾滋病毒感染者(PWUD)的纵向研究中,确定与抗逆转录病毒疗法最佳依从性的转入和转出相关的因素。利用来自社区招募的艾滋病毒呈阳性非法药物使用者的前瞻性队列数据,这些数据与全面的艾滋病毒/艾滋病治疗记录进行了保密关联,我们使用两个广义线性混合效应模型估计了与前六个月依从性丧失或获得≥95%相关的纵向因素。在703名接受抗逆转录病毒疗法的艾滋病毒感染PWUD中,依从性下降与无家可归时期(调整后的优势比[AOR]=2.52,95%置信区间[95%CI]:1.56 - 4.07)、活跃注射吸毒(AOR = 1.25,95%CI:1.01 - 1.56)和监禁(AOR = 1.54,95%CI:1.10 - 2.17)相关。性工作时期(AOR = 0.51,95%CI:0.34 - 0.75)和注射吸毒(AOR = 0.62,95%CI:0.50 - 0.77)是实现最佳依从性的障碍。美沙酮维持治疗与实现最佳依从性相关(AOR = 1.87,95%CI:1.50 - 2.33),并可预防依从性下降(AOR = 0.52,95%CI:0.41 - 0.65)。总之,我们确定了几个影响PWUD依从模式的行为、社会和结构因素。我们的研究结果强调在支持向该人群有效提供抗逆转录病毒疗法的干预措施中需要考虑这些背景因素。